Smithfield Trust’s Integra LifeSciences IART Stock Holding History

Smithfield Trust’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-120	Closed	-$3K	–	1064
2024 Q3	$3K	Hold	120	–	–	﹤0.01%	980
2024 Q2	$3K	Hold	120	–	–	﹤0.01%	950
2024 Q1	$3K	Hold	120	–	–	﹤0.01%	975
2023 Q4	$6K	Hold	120	–	–	﹤0.01%	906
2023 Q3	$6K	Hold	120	–	–	﹤0.01%	881
2023 Q2	$6K	Hold	120	–	–	﹤0.01%	895
2023 Q1	$6K	Hold	120	–	–	﹤0.01%	862
2022 Q4	$6K	Hold	120	–	–	﹤0.01%	861
2022 Q3	$6K	Hold	120	–	–	﹤0.01%	868
2022 Q2	$6K	Hold	120	–	–	﹤0.01%	923
2022 Q1	$9K	Hold	120	–	–	﹤0.01%	863
2021 Q4	$9K	Hold	120	–	–	﹤0.01%	871
2021 Q3	$9K	Hold	120	–	–	﹤0.01%	871
2021 Q2	$8K	Hold	120	–	–	﹤0.01%	884
2021 Q1	$8K	Hold	120	–	–	﹤0.01%	905
2020 Q4	$8K	Hold	120	–	–	﹤0.01%	869
2020 Q3	$6K	Buy	+120	New	+$5.71K	﹤0.01%	886

Other funds holding IART

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Smithfield Trust's IART Position: Q4 2024 in Review

Smithfield Trust sold out of Integra LifeSciences (IART) in Q4 2024, closing a stake of 120 shares — an estimated $3K sold.

Smithfield Trust first reported a position in IART in Q3 2020 and held it in 17 quarters. The position peaked at $9K in Q1 2022. 223 funds tracked by Wall St. Rank hold IART as of Q4 2024.

Smithfield Trust reported no remaining Integra LifeSciences position as of Q4 2024 after selling out during the quarter.
Smithfield Trust sold 120 Integra LifeSciences shares in Q4 2024, an estimated $3K.
Smithfield Trust first reported a position in Integra LifeSciences in Q3 2020 and held it in 17 quarters.
Smithfield Trust's Integra LifeSciences position peaked at $9K in Q1 2022.
223 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2024.

Based on Smithfield Trust's 13F filing for Q4 2024, filed 6 Feb 2025.